Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bern Daily Press.
Press releases published on August 19, 2025


USIA présente Red Art Project, une exposition commissariée par Francisco Lacerda
USIA présente RED ART PROJECT : des artistes internationaux réinventent la puissance du rouge dans une exposition commissariée par Francisco Lacerda GENèVE , SWITZERLAND, August 19, 2025 /EINPresswire.com/ -- USIA (United State of International Artists …

Crown Point Capital Rolls Out Global Investor Protection Program This Quarter
Zurich, Switzerland, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Crown Point Capital has officially announced the launch of its Global Investor Protection Program, set to roll out this quarter. As part of the company’s continuing evolution as a premier crypto …

TRYVIO™ (aprocitentan) now included in ACC/AHA Clinical Practice Guidelines for the treatment of hypertension
The updated recommendations now include TRYVIO™ (aprocitentan) – the first and only hypertension treatment targeting the endothelin pathway. Endothelin is upregulated in hypertension and is a fundamental mediator in patients whose hypertension is difficult …

Memo Therapeutics AG Publishes Phase I Safety, Tolerability, and Pharmacokinetics Study for Neutralizing Antibody Targeting BKPyV Infection in Clinical and Translational Science
First-in-human, Phase I, randomized, placebo-controlled study, successfully demonstrated safety and tolerability of potravitug in healthy volunteers The Company recently announced the results from its Phase II placebo-controlled clinical trial of …

Sportradar Strengthens Bundesliga International Relationship With Launch of Innovative New Products Starting 2025-26 Season
ST. GALLEN, Switzerland and FRANKFURT, Germany, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Bundesliga International is strengthening its longstanding agreement with Sportradar Group AG (NASDAQ: SRAD) to further enhance the viewing experience, accelerate innovation …

Basilea mit starkem Halbjahresergebnis 2025 auf Kurs
Cresemba- und Zevtera-basierte Umsätze steigen um 24 % auf CHF 90.5 Mio. Gesamtumsatz steigt signifikant um 36 % auf CHF 104.0 Mio. Betriebsgewinn springt um 160 % auf CHF 24.0 Mio. Operativer Cashflow erhöht sich um 29 % auf CHF 23.1 Mio. Guidance für das …

Basilea on track with strong 2025 half-year results
Cresemba® and Zevtera®-related revenues rise by 24% to CHF 90.5 million Total revenue grows significantly by 36% to CHF 104.0 million Operating profit surges by 160% to CHF 24.0 million Operating cash flow increases by 29% to CHF 23.1 million Full-year …

Santhera schließt Vereinbarung mit Uniphar über den Vertrieb von AGAMREE® (Vamorolon) in fünf Ländern des Golf-Kooperationsrats (GCC)
Pratteln, Schweiz, 19. August 2025 – Santhera Pharmaceuticals (SIX: SANN) gibt die Unterzeichnung einer exklusiven Vereinbarung mit Uniphar über den Vertrieb von AGAMREE® (Vamorolon) in den Vereinigten Arabischen Emiraten, Saudi-Arabien, Kuwait, Oman und …

Santhera Secures Agreement with Uniphar for the Distribution of AGAMREE® (Vamorolone) in five GCC (Gulf Cooperation Council) Countries
Pratteln, Switzerland, 19 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE® (vamorolone) in the United Arab Emirates, the Kingdom of Saudi Arabia, Kuwait, …